Fournier’s gangrene

Cover Page


Cite item

Full Text

Abstract

The review highlights the issues of etiology, pathogenesis, clinical and laboratory picture, radiodiagnosis, treatment and prognosis of fulminant perineum gangrene, or Fournier’s gangrene. According to modern concepts, Fournier’s gangrene is one of the rare forms of necrotizing fasciitis of polymicrobial etiology with a primary lesion of the skin, subcutaneous tissue and superficial fascia of the scrotum, penis, and perineum. Fournier’s gangrene refers to acute surgical diseases of pyonecrotic nature and is characterized by rapid septic course, high mortality, reaching 80%, in spite of the modern antibiotic therapy advances. Over the last decade the Fournier’s gangrene incidence increased in 2.2-6.4 times, due to the increasing number of immunocompromised patients in the population. The disease most often occurs in older men with diabetes, alcoholism and obesity. The Fournier’s gangrene occurrence is preceded by different inflammatory diseases of the colon, urinary organs, scrotum and perineum skin. The disease diagnosis in full-scale stage usually is not difficult. In rare cases, namely in the disease early stages, various radiological methods of investigation, laboratory tests and exploratory surgery with affected soft tissues express biopsy are used with differential diagnosis purposes. The cornerstone in the Fournier’s gangrene treatment is an emergency surgical intervention in combination with a powerful anti-bacterial and anti-shock therapy. To improve the wound healing course and reduce the septic complications risk, new methods of adjuvant treatments such as hyperbaric oxygen therapy and vacuum therapy are used. Hospitalization duration in Fournier’s gangrene is usually lengthy, due to the need to use repeated sanitation necrectomy and reconstructive plastic surgery and are associated with considerable economic costs for treatment. The Fournier’s gangrene prognosis depends on the timing of specialized medical care provision and, above all, on the time interval between the disease onset and surgery performing.

About the authors

A V Prokhorov

City Clinical Hospital №57

Author for correspondence.
Email: botex@rambler.ru

References

  1. Алиев С.А., Алиев Е.С., Зейналов В.М. Болезнь Фурнье в свете современных представлений. Хирургия. Ж. им. Н.И. Пирогова. 2014; (4): 34-39.
  2. Гринев М.В., Сорока И.В., Гринев К.М. Гангрена Фурнье - модель некротизирующего фасцита (клинические и патогенетические аспекты). Урология. 2007; (6): 69-73.
  3. Ефименко Н.А., Привольнев В.В. Гангрена Фурнье. Клин. микробиол. и антимикроб. химиотерап. 2008; 10 (1): 34-42.
  4. Каштальян М.А., Герасименко О.С., Околец В.П., Масунов К.Л. Хирургическое лечение некротических инфекций мягких тканей. Шпитальна Хiрургiя. 2013; (3): 96-98.
  5. Привольнев В.В. Гангрена Фурнье. Мед. вестн. МВД. 2013; 67 (6): 26-32.
  6. Тимербулатов В.М., Хасанов А.Г., Тимербулатов М.В. Гангрена Фурнье. Хирургия. Ж. им. Н.И. Пирогова. 2009; (3): 26-28.
  7. Черепанин А.И., Светлов К.В., Чернов А.Ф., Бармин Е.В. Другой взгляд на «болезнь Фурнье в практике хирурга». Хирургия. Ж. им. Н.И. Пирогова. 2009; (10): 47-50.
  8. Agostini T., Mori F., Perello R. et al. Successful combined approach to a severe Fournier’s gangrene. Indian. J. Plast. Surg. 2014; 47:132-136. http://dx.doi.org/10.4103/0970-0358.129648
  9. Altarac S., Katusin D., Crnica S. et al. Fournier’s gangrene: etiology and outcome analysis of 41 patients. Urol. Int. 2012; 88: 289-293. http://dx.doi.org/10.1159/000335507
  10. Barreda J.T., Scheiding M.M., Fernandez C.S. et al. Fournier’s gangrene. A retrospective study of 41 cases. Cir. Esp. 2010; 87: 218-223.
  11. Benjelloun E.B., Souiki T., Yakla N. et al. Fournier’s gangrene: our experience with 50 patients and analysis of factors affecting mortality. WJES. 2013; 8: 1-5. http://dx.doi.org/10.1186/1749-7922-8-13
  12. Eke N. Fournier’s gangrene: a review of 1726 cases. British J. Surg. 2000; 87: 85-87. http://dx.doi.org/10.1046/j.1365-2168.2000.01497.x
  13. Eskitascioglu T., Ozyazgan I., Coruh A. et al. Experience of 80 cases with Fournier’s gangrene and «trauma» as a trigger factor in the etiopathogenesis. Ulus. Travma Acil. Cerrahi Derg. 2014; 20: 265-274. http://dx.doi.org/10.5505/tjtes.2014.67670
  14. Ersoz F., Sari S., Arikan S. et al. Factors affecting mortality in Fournier’s gangrene: experience with fifty-two patients. Singapore Med. J. 2012; 53: 537-540.
  15. Erol B., Tuncel A., Hanci V. et al. Fournier’s gangrene: overview of prognostic factors and definition of new prognostic parameter. Urology. 2010; 75: 1193-1198. http://dx.doi.org/10.1016/j.urology.2009.08.090
  16. Fall B., Fall P.A., Diao B. et al. Fournier’s gangrene; a review of 102 cases. Andrologie. 2009; 19: 45-49. http://dx.doi.org/10.1007/s12610-008-0003-x
  17. Hakkarainen T.W., Kopare N.M., Fellow B., Evans H.L. Necrotizing soft tissue infections; review and current concepts in treatment, systems of care, and outcomes. Curr. Probl. Surg. 2014; 51: 344-362. http://dx.doi.org/10.1067/j.cpsurg.2014.06.001
  18. Herlin C. Negative pressuretherapy in the loss of perineal substance. Soins. 2014; (782): 37-38.
  19. Khandelwal R., Chintamani С., Tandon M. et al. Fournier’s gangrene severity index as a predictor of outcome in patients with Fournier’s gangrene: a prospective clinical study at a tertiary care center. J. Young Med. Researchers. 2013; 1: 1-5.
  20. Laor E., Palmer L.S., Tolia B.M. et al. Outcome prediction in patients with Fournier’s gangrene. J. Urol. 1995; 154: 89-92. http://dx.doi.org/10.1016/S0022-5347(01)67236-7
  21. Levenson R.B., Singh A.K., Novelline R.A. Fournier gangrene: role of imaging. Radiographics. 2008; 28: 519-528. http://dx.doi.org/10.1148/rg.282075048
  22. Martinschek A., Evers B., Lampl L. et al. Prognostic aspects, survival rate, and predisposing risk factors in patients with Fournier’s gangrene and necrotizing soft tissue infections: evaluation of clinical outcome of 55 patients. Urol. Int. 2012; 89: 173-179. http://dx.doi.org/10.1159/000339161
  23. Morykwas M.J., Simpson J., Punger K. et al. Vacuum-assisted closure: state of basic research and physiologic foundation. Plast. Reconstr. Surg. 2006; 117: 121S-126S.
  24. Sorensen M.D., Krieger J.N., Rivara F.P. et al. Fournier’s gangrene: management and mortality predictors in a population based study. J. Urol. 2009; 182: 2742-2747. http://dx.doi.org/10.1016/j.juro.2009.08.050
  25. Shyam D.C., Rapsang A.G. Fournier’s gangrene. Surgeon. 2013; 11: 222-232. http://dx.doi.org/10.1016/j.surge.2013.02.001
  26. Shaw J.J., Psoinos C., Emhoff T.A. et al. Not just full of hot air: hyperbaric oxygen therapy increases survival in cases of necrotizing soft tissue infections. Surg. Infect. (Larchmt). 2014; 15: 328-335. http://dx.doi.org/10.1089/sur.2012.135
  27. Wroblewska M., Kuzaka B., Borkowski T. et al. Fournier’s gangrene - current concepts. Polish J. of Microbiol. 2014; 63: 267-273.
  28. Willy C., Rieger H., Vogt D. Hyperbaric oxygen therapy for necrotizing soft tissue infections: contra. Chirurg. 2012; 83: 960-972. http://dx.doi.org/10.1007/s00104-012-2284-z
  29. Wong C.H., Khin L.W., Heng K.S. et al. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit. Care. Med. 2004; 32: 1535-1541. http://dx.doi.org/10.1097/01.CCM.0000129486.35458.7D
  30. Ye J., Xie T., Wu M. et al. Negative pressure wound therapy applied before and after split-thickness skin graft helps healing of Fournier gangrene: a case report. Medicine (Baltimore). 2015; 94: e426.

Supplementary files

Supplementary Files
Action
1. JATS XML

© 2016 Prokhorov A.V.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.





This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies